# OnCo record ahcc-shiitake-extract (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/ahcc-shiitake-extract/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "ahcc-shiitake-extract" ;
  schema:name "AHCC (active hexose correlated compound)"@en ;
  schema:alternateName "Active hexose correlated compound"@en ;
  schema:description "AHCC is a proprietary extract of shiitake mushroom mycelium taken to prevent and treat cancer. Early studies hint at fewer chemotherapy side effects and better outcomes after liver cancer surgery, but in a multicentre study in early prostate cancer it did not lower the blood marker it was meant to. It may weaken aromatase inhibitors."@en ;
  schema:url <https://onco.cc/technologies/ahcc-shiitake-extract/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/ahcc>, <https://www.cancer.gov/about-cancer/treatment/cam/hp/mushrooms-pdq> ;
  onco:status "phase-2" ;
  onco:tag "complementary", "supportive-care", "evidence:insufficient" ;
  onco:related <https://onco.cc/technologies/medicinal-mushrooms-reishi-turkey-tail/>, <https://onco.cc/technologies/maitake-mushroom/>, <https://onco.cc/technologies/agaricus-blazei/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/nutrition-lifestyle/> ;
  onco:technologies <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ondansetron/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/anastrozole/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> .